Alterome Therapeutics Stock

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Sign up today and learn more about Alterome Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Alterome Therapeutics Stock

Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.

Funding History

January 2022$64.0M
November 2022$35.0M

Management

Board Member

Arjun Goyal

Board Member

Carl L. Gordon

Senior Vice President Nonclinical Research

Sanjeev Thohan

Board Member

Thilo Schroeder

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo